Kaku, K., Lee, J., Mattheus, M., Kaspers, S., George, J., Woerle, H., . . . Malano, J. (2017). Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME®.
Citación estilo ChicagoKaku, K., et al. Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME®. 2017.
Cita MLAKaku, K., et al. Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME®. 2017.
Precaución: Estas citas no son 100% exactas.